Pharmacology Study in CD-1 Mice

INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA) the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Charles River Laboratories, Inc. Three Biotech, One Innovation Drive, Worcester, MA 01605 for Pharmacology Study in CD-1 Mice. NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS The intended procurement is classified under NAICS 541380 Testing Laboratories and Services with a Size Standard of $16.50. REGULATORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13'Simplified Acquisition Procedures. Contracts awarded using FAR Part 13'Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6'Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single source provides that: For purchases not exceeding the simplified acquisition threshold, Contracting officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization). The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2022-08 dated October 22, 2022. DESCRIPTION OF REQUIREMENT PURPOSE AND OBJECTIVES: Pharmacology Study in CD-1 Mice. In order to analyze the efficacy of a series of small molecules in vivo, it is necessary to treat animals with the small molecules, collect the tissues, and arrange for shipment of those tissues to another site for analysis. Purchase Description: This requisition is for the following. 1. Formulation and administration of 7 small molecule agents to 21 CD-1 mice (3 mice per agent) 2. Formulation and administration of 1 control placebo to 3 CD-1 mice. 3. Euthanization of the mice after 4 to 8 hours 4. Collection of select organ systems from the mice for all samples. 5. Flash freezing and shipment of the organ systems to NCATS for analysis. 6. Shipment to NCATS will be by World Courier (preferred) ESTIMATED PERIOD OF PERFORMANCE: Period of performance is within four (4) months from the contract award and receipt of first batch of material CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted. Specifically, Charles River Laboratories, Inc. Three Biotech, One Innovation Drive, Worcester, MA 01605 is the only vendor in the marketplace that can provide the services required by NIDA . The intended source is: Charles River Laboratories, Inc. Three Biotech, One Innovation Drive Worcester, MA 01605 CLOSING STATEMENT THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must be received by the closing date and time of this announcement and must reference the solicitation number, 75N95023Q00566. Responses must be submitted electronically to Kaitlyn Landi, Contract Specialist, at contact@example.gov and KJ Shaikh, Contracting Officer, at contact@example.gov. U.S. Mail and fax responses will not be accepted.